These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8980761)

  • 1. Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model.
    Marley SE; Eberhard ML; Steurer FJ; Ellis WL; McGreevy PB; Ruebush TK
    Antimicrob Agents Chemother; 1997 Jan; 41(1):91-4. PubMed ID: 8980761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atovaquone in the treatment of Babesia microti infections in hamsters.
    Wittner M; Lederman J; Tanowitz HB; Rosenbaum GS; Weiss LM
    Am J Trop Med Hyg; 1996 Aug; 55(2):219-22. PubMed ID: 8780464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
    Wormser GP; Prasad A; Neuhaus E; Joshi S; Nowakowski J; Nelson J; Mittleman A; Aguero-Rosenfeld M; Topal J; Krause PJ
    Clin Infect Dis; 2010 Feb; 50(3):381-6. PubMed ID: 20047477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of 19 antiprotozoal drugs and antibiotics on Babesia microti infection in BALB/c mice.
    Yao JM; Zhang HB; Liu CS; Tao Y; Yin M
    J Infect Dev Ctries; 2015 Sep; 9(9):1004-10. PubMed ID: 26409742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of azithromycin for treating Babesia microti infection in the hamster model.
    Weiss LM; Wittner M; Wasserman S; Oz HS; Retsema J; Tanowitz HB
    J Infect Dis; 1993 Nov; 168(5):1289-92. PubMed ID: 8228366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tafenoquine for Relapsing Babesiosis: A Case Series.
    Krause PJ; Rogers R; Shah MK; Kang H; Parsonnet J; Kodama R; Vannier E
    Clin Infect Dis; 2024 Jul; 79(1):130-137. PubMed ID: 38814096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could the Drug Tafenoquine Revolutionize Treatment of Babesia microti Infection?
    Mordue DG; Wormser GP
    J Infect Dis; 2019 Jul; 220(3):442-447. PubMed ID: 31099380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo.
    Carvalho LJM; Tuvshintulga B; Nugraha AB; Sivakumar T; Yokoyama N
    Parasit Vectors; 2020 Jul; 13(1):362. PubMed ID: 32690081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmaniasis: in search of new chemotherapeutic agents.
    Kinnamon KE; Steck EA; Loizeaux PS; Chapman WL; Waits VB; Hanson WL
    Am J Vet Res; 1980 Mar; 41(3):405-7. PubMed ID: 7369615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel diamidines with activity against Babesia divergens in vitro and Babesia microti in vivo.
    Nehrbass-Stuedli A; Boykin D; Tidwell RR; Brun R
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3439-45. PubMed ID: 21537025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy against babesiosis.
    Vial HJ; Gorenflot A
    Vet Parasitol; 2006 May; 138(1-2):147-60. PubMed ID: 16504402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful prevention and treatment of babesiosis with atovaquone.
    Hughes WT; Oz HS
    J Infect Dis; 1995 Oct; 172(4):1042-6. PubMed ID: 7561178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent parasitemia after acute babesiosis.
    Krause PJ; Spielman A; Telford SR; Sikand VK; McKay K; Christianson D; Pollack RJ; Brassard P; Magera J; Ryan R; Persing DH
    N Engl J Med; 1998 Jul; 339(3):160-5. PubMed ID: 9664092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate, a potential drug for treatment of Babesia infection.
    Goo YK; Terkawi MA; Jia H; Aboge GO; Ooka H; Nelson B; Kim S; Sunaga F; Namikawa K; Igarashi I; Nishikawa Y; Xuan X
    Parasitol Int; 2010 Sep; 59(3):481-6. PubMed ID: 20541037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of naphthoquine phosphate on Babesia gibsoni in vitro and Babesia rodhaini in vivo.
    Ji S; Liu M; Galon EM; Rizk MA; Tuvshintulga B; Li J; Zafar I; Hasegawa Y; Iguchi A; Yokoyama N; Xuan X
    Parasit Vectors; 2022 Jan; 15(1):10. PubMed ID: 34991686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sitamaquine (GlaxoSmithKline/Walter Reed Army Institute).
    Yeates C
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1446-52. PubMed ID: 12431016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of Babesia microti infections in Mongolian Jirds.
    Ruebush TK; Contacos PG; Steck EA
    Antimicrob Agents Chemother; 1980 Aug; 18(2):289-91. PubMed ID: 7447406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atovaquone and azithromycin for the treatment of babesiosis.
    Krause PJ; Lepore T; Sikand VK; Gadbaw J; Burke G; Telford SR; Brassard P; Pearl D; Azlanzadeh J; Christianson D; McGrath D; Spielman A
    N Engl J Med; 2000 Nov; 343(20):1454-8. PubMed ID: 11078770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Babesia microti infection in the hamster: failure of quinine and pyrimethamine in chemotherapeutic trials.
    Marcus LC; Mabray CJ; Sturgis GH
    Am J Trop Med Hyg; 1984 Jan; 33(1):21-3. PubMed ID: 6696180
    [No Abstract]   [Full Text] [Related]  

  • 20. Babesia microti infection in Europe.
    Meer-Scherrer L; Adelson M; Mordechai E; Lottaz B; Tilton R
    Curr Microbiol; 2004 Jun; 48(6):435-7. PubMed ID: 15170239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.